|Publication number||US7169577 B2|
|Application number||US 10/206,340|
|Publication date||Jan 30, 2007|
|Filing date||Jul 29, 2002|
|Priority date||Jul 27, 2001|
|Also published as||US20030032002|
|Publication number||10206340, 206340, US 7169577 B2, US 7169577B2, US-B2-7169577, US7169577 B2, US7169577B2|
|Inventors||Evelyn Wang, Rocco Casagrande, Amar Kendale, Enoch Kim, Emanuele Ostuni, Olivier Schueller|
|Original Assignee||Surface Logix, Inc.|
|Export Citation||BiBTeX, EndNote, RefMan|
|Patent Citations (90), Non-Patent Citations (22), Referenced by (9), Classifications (31), Legal Events (7)|
|External Links: USPTO, USPTO Assignment, Espacenet|
This application is a continuation-in-part application of U.S. application Ser. No. 10/084,063, filed Feb. 28, 2002 and claims priority to Provisional U.S. Application No. 60/334,593 filed Dec. 3, 2001, and Provisional U.S. Application No. 60/307,843 filed Jul. 27, 2001, [and U.S. application Ser. No. 10/084,063 filed Feb. 28, 2002] all of which are herein incorporated by reference in their entirety.
The present invention relates to devices and methods that are useful for isolating and screening cells for a desired biological activity. In particular, the present invention relates to devices and methods that are useful in isolating and screening hybridoma cells for specific antibody production.
One of the major challenges for performing cell based screening is the isolation of small populations of cells in a manner that allows for subsequent screening procedures. Traditional devices and methods of isolating cells do not adequately provide for the isolation of small populations of cells without performing steps that potentially modify cellular function or activity. Isolation of cells is not only important in screening, but also in processes that involve the monitoring, measuring, and/or use of the output of cellular activity or function (e.g. antibody production) for small populations of cells.
For example, with respect to antibody production, one of the approaches used to produce antibodies is to manufacture hybridomas. These are cells created by the fusion of antibody-secreting B-cells and myeloma cells. This method is variable with respect to almost all stages of the process including the duration of screening and required needs for cell growth and proliferation. Much of the variability can be attributed to the immunogen and immune response mounted by the immunized animal. Moreover this process is time consuming and labor intensive.
In general, once the fusion is performed and the cells are plated, there are several issues that have to be addressed. First, the cells will grow at different rates, thus the point at which one must perform the assay for antibody production to assess positive pools of cells can vary and may require more than one assay point on the same pool of cells. During this process, the rapidly growing cells need to be passaged in order to promote viability and to prevent loss of potentially positive clones. The next step is to perform limiting dilution with the goal of achieving clonal populations. Successive rounds of this process may be required to achieve clonal or near clonal populations.
The value of specific monoclonal antibodies as useful tools for diagnostics and immuno-therapies has meant that investigators have had no alternative but to tolerate long production periods and high development costs. Rapid and efficient ways of screening hybridoma cell lines for antibody production are not presently available. Therefore, there is a need for methods and devices to accelerate monoclonal antibody production for experimental, diagnostic and therapeutic applications. The devices and methods disclosed herein dramatically shorten the period for monoclonal antibody production from a period of weeks to a period of days. The invention provides a multicomponent device that also has application for other cell types requiring the isolation of a small population of cells and requiring the subsequent clonal expansion of this population of cells.
The present invention relates to devices and methods for screening a cell or small group of cells for a desired biological activity comprising a cell delivery step, a cell isolation device and a corresponding cell isolation step, a cell expansion device and a corresponding cell expansion step, and a detection device and a corresponding detection step.
In particular, the present invention provides a method of screening cells for a desired biological activity comprising providing a cell isolation device defining a plurality of cell isolation regions, each cell isolation region encompassing a recess, each of the cell isolation regions being sized to isolate about one to about five cells therein, and the cell isolation regions further defining a predetermined pitch with respect to one another. The method further comprises delivering the about one cell to about five cells to each of the cell isolation regions. The method additionally comprises providing a cell expansion device defining a plurality of wells corresponding to respective ones of the plurality of cell isolation regions, the wells defining a predetermined pitch matching the predetermined pitch of the cell isolation regions. The method also comprises transferring the about one cell to about five cells from the cell isolation regions to the wells and allowing the about one cell to about five cells to proliferate and exhibit a desired biological activity in the wells. The method further comprises assaying the desired biological activity of the one cell to about five cells.
The present invention also provides a kit for screening cells for a desired biological activity, the kit comprising a cell isolation device defining a plurality of cell isolation regions, each cell isolation region encompassing a recess, each of the cell isolation regions being sized to isolate about one to about five cells therein, and the cell isolation regions further defining a predetermined pitch with respect to one another. The kit further comprises a cell expansion device defining a plurality of wells corresponding to respective ones of the plurality of cell isolation regions, and the wells defining a predetermined pitch matching the predetermined pitch of the cell isolation regions.
The present invention will become more fully understood from the detailed description given hereinbelow and the accompanying drawings which are given by way of illustration only, and thus are not limitative of the present invention, and wherein:
The present invention relates to methods and devices for isolating a small population of cells and for screening a larger population of proliferated cells for biological activity with a minimal amount of manipulation of the cells. Although the present invention contemplates the screening of all types of cells for the detection of any desired biological activity, for purposes of illustration, the methods and devices described herein are occasionally described in the context of isolating and screening hybridoma cells for specific antibody production. The present invention is not in any way limited to this application and may be used to isolate any types of cells, including, but not limited to, cell lines that express or produce proteins, carbohydrates, enzymes, peptides, hormones, receptors; other cell lines that produce antibodies; genetically engineered cells; and activated cells. Moreover, the present invention may be used to screen for a variety of biological activities including, but not limited to, the expression of surface receptor proteins, enzyme production, and peptide production. Furthermore, the present invention may be used to screen a variety of test agents to determine the effect of the test agents on the desired biological activity. Other types of cells desired to be isolated and screened, other types of biological activity desired to be detected, and specific test agents to be screened will be readily appreciated by one of skill in the art.
In general, the present invention relates to a method and accompanying device for isolating and screening cells including a cell delivery step, a cell isolation step utilizing a cell isolation device, a cell expansion step utilizing a cell expansion device, and a detection step utilizing a detection device. In general, cells are delivered to cell isolation regions of the cell isolation device. By “cell isolation region” is meant any area capable of attracting, trapping, securing and/or binding a single cell or a small population of cells. Cell are then transferred to wells of a cell expansion device. By “well” is meant a cavity that is capable of retaining cells therein. Cells are then transferred from the cell expansion device to the detection device where biological activity is detected, or, in the alternative, the detection device is brought into contact with the cell expansion device.
With respect to particular details of the methods and devices according to the present invention, in the cell delivery step, cells may be delivered to the cell isolation regions of the cell isolation device (described in more detail below) by any means known in the art. For example, cells may be delivered by directly pipetting cells into or on the cell isolation regions of the cell isolation device either manually or by robotic liquid handling systems; bulk delivering the cells in fluid to the cell isolation device and removing the excess by pipetting so as to leave only cells in or on the cell isolation regions; or by utilizing a delivery device with microfluidic channels to deliver the cells into or on the cell isolation regions.
With respect to the use of microfluidic device 200 according to the present invention, as seen in
In some embodiments of the present invention, preferably the flow of the cell containing medium into the cell isolation regions is constant, or continuous. Typically, a known and/or constant flow rate is useful, for example, when attempting to establish precise control over the delivery of cells to cell isolation regions 20. Furthermore, constant flow facilitates feeding of cells and high throughput screening.
In one embodiment of the method of delivering cells to cell isolation device 10 according to the present invention, microfluidic device 200 is used to deliver about fifty to about hundred cells to each cell isolation region 20. In another embodiment, microfluidic device 200 is used to deliver about twenty-five to about fifty cells to each cell isolation region 20. In yet another embodiment, microfluidic device 200 is used to delivery about ten to about twenty-five cells to each cell isolation region 20. In another embodiment, microfluidic device 200 is used to delivery about five to about ten cells to each cell isolation region 20. In still another embodiment, microfluidic device is used to delivery about one to about five cells to each cell isolation region 20. In a preferred embodiment, microfluidic device is used to deliver a single cell to each cell isolation region 20. Typically, about 90% of each of the cell isolation regions 20 of the cell isolation device 10 are filled when the flow rate is adjusted or regulated. The flow rate by which the cell containing medium is delivered to the cell isolation regions 20 can be adjusted by known methods. A person of skill in the art would know how to adjust the flow rate of a microfluidic device to achieve a desired cell distribution per cell isolation region 20.
Microfluidic device 200 may be fabricated from materials that are compatible with the conditions present in the particular experiment of interest. Such conditions include, but are not limited to, pH, temperature, ionic concentration, pressure, and application of electrical fields. The materials of device 200 may also be chosen for their inertness to components of the experiment to be carried out in the device. Such materials include, but are not limited to, glass, silicon, fused silica, metal films, polymeric substrates, such as polystyrene, poly(methylacrylate), polydimethylsiloxane (PDMS) and polycarbonate, depending on the intended application.
Notwithstanding the method of delivery, according to embodiments of the present invention, cells are ultimately delivered to cell isolation device 10 where cells are isolated. As illustrated in
In another embodiment of the cell isolation device, as seen in
Notwithstanding the type of cell isolation region 20 utilized, preferably adjacent cell isolation regions 20 are disposed relative to one another to define a predetermine pitch. More, preferably, the cell isolation regions 20 are disposed relative to one another to match a pitch P of an industry standard microtiter plate such as, for example, a 24-, 96-, 384-, 768-, or a 1536-well microtiter plate. The term “pitch” P as used herein in reference to the cell isolation device, the cell expansion device, and the cell detection device, refers to the distance between respective vertical centerlines between adjacent cell isolation regions 20 in the test orientation of the particular device being utilized. By “test orientation” of the device is meant to refer to a spatial orientation of the cell isolation device of the particular device being utilized during its respective step. For example, the test orientation of the cell isolation device 10 is the orientation of the device when cells are isolated in their respective cell isolation regions 20. The test orientation of the cell expansion device is the orientation of the cell expansion device when cells are allowed to proliferate in their respective wells. It is also noted that in the context of the present invention, “top,” “bottom,” and “lateral” are defined relative to the test orientation of the cell isolation device.
Although the present invention contemplates both the isolation of a single cell 30 and small groups of cells 30, in certain embodiments it may be preferable to isolate a single cell 30. Examples of such embodiments include the embodiments of
The present invention contemplates several methods of fabricating cell isolation device 10 a wherein cell isolation region 20 a of device 10 a is defined a microwell portion 52 and accessory delivery portions such as conical portion 51 and optionally cylindrical portion 50. Referring to
As illustrated in
As shown in
As shown in
Materials for cell isolations device 10 a include any rigid or flexible machinable material such as glass, co-polymer or polymer, most preferably urethane, rubber, molded plastic, polymethyl methacrylate (PMMU), polycarbonate, polytetrafluoroethylene (TEFLON), polyvinyl chloride (PVC), polydimethylsiloxane (PIMS), polysulfone, and the like.
Cell isolation device 10 a (whether designed to isolate a single cell or a group of cells) may be exposed to differential surface treatment in order to ensure that cells are isolated in cell isolation region 20 a. For example, the areas of housing 11 surrounding cell isolation regions 20 a may be treated to reduce protein adhesion while cell isolation regions 20 a may be treated to provide a more hydrophilic environment. The hydrophilic nature of cell isolation region 20 a versus the surrounding hydrophobic housing 11 would favor the beading of liquid containing cells 30 in cell isolation region 20 a and potentially hold cells 30 in place, limiting the exhibition of biological activity, such as antibody deposition, to the “wet” areas. Examples of some hydrophobic surface treatments known in the art are teflon, perfluoronated plastic, and polyethylene glycol.
In another embodiment of the cell isolation device 10 according to the present invention, cell isolation device 10 b comprises a surface 40 having a plurality of cell isolation regions 20 b as seen in
With respect to non-specific affinity, exemplary bioaffinity ligands having a general non-specific affinity to cells are the lanthanides and in particular, erbium, which is known to bind cell surface glycoproteins as well as calcium-receptors. Another bioaffinity ligand having a general non-specific affinity to cells is ferritin.
In another embodiment, the bioaffinity ligand is an antibody specific for mammalian cells. For example, anti-Ig kappa light chain antibody, anti-CD45R antibody, or anti-syndecan, may be used to differentially bind activated B-cells. Preferably, an antibody specific for anti-Ig kappa light chain antibody cells is used. Any of the methods known in the art for conjugating an antibody to a solid phase support, such as surface 40 described herein, can be used in the present invention.
The use of SAMs provides a preferred method for binding and isolating cells 30 in the bioaffinity region of cell isolation region 20 b. SAMs are the most widely studied and best developed examples of nonbiological, self-assembling systems. They form spontaneously by chemisorption and self-organization of functionalized, long-chain organic molecules onto the surfaces of appropriate substrates. SAMS are usually prepared by immersing a substrate in the solution containing a ligand that is reactive toward the surface, or by exposing the substrate to the vapor of the reactive species. As is well-known to one of skill in the art, there are many systems known in the art to produce SAMs. In certain embodiments, it may be desirable to pattern the SAMs to have an arrayed surface. Patterning SAMs on a planar surface has been achieved by a wide variety of techniques, including micro-contact printing, photo-oxidation, photo-cross-linking, photo-activation, photolithography/plating, electron beam writing, focused ion beam writing, neutral metastable atom writing, SPM lithography, micro-machining, micro-pen writing. A preferred method is micro-contact printing is described in U.S. Pat. No. 5,776,748 and is herein incorporated by reference in its entirety.
With respect to the dimensions of cell isolation region 20 b according to the embodiment of
As with cell isolation device 10 a, cell isolation device 10 b may be exposed to differential surface treatment in order to ensure that cells are isolated in cell isolation region 20 b. For example, the areas of surface 40 surrounding cell isolation regions 20 b may be treated, for example, with a hydrophobic surface treatment, to reduce protein adhesion. The bioaffinity region of cell isolation region 20 a and the surrounding hydrophobic area of surface 40 would favor the binding of cells 30 on cell isolation region 20 b. Examples of some hydrophobic surface treatments known in the art are teflon, perfluoronated plastic, and polyethylene glycol.
Although the description of the foregoing embodiments has focused on the use of bioaffinity ligands to bind cells 30 onto cell isolation region 20 b of cell isolation device 10 b, it is also contemplated by the present invention that bioaffinity ligands may be immobilized on the bottom surface of cell isolation regions 20 a of cell isolation device 10 a to potentially bind cells 30.
With respect to surface 40 of cell delivery device 10 b, surface 40 may be fabricated of any material capable of having bioaffinity ligands immobilized therein and such materials are readily known to one of skill in the art. Preferably, surface 40 is fabricated of any rigid or flexible machinable material such as glass, co-polymer or polymer, most preferably urethanes, rubber, molded plastic, polymethylmethacrylate (PMMA), polycarbonate, polytetrafluoroethylene (TEFLONTM), polyvinylchloride (PVC), polydimethylsiloxane (PDMS), polysulfone, and the like. Such substrates are readily manufactured from microfabricated masters, using well known molding techniques, such as injection molding, embossing or stamping, or by polymerizing the polymeric precursor material within a mold. Standard soft lithography techniques may also be used to fabricate surface 40 (see e.g., Love, et al., MRS BULLETIN, pp. 523–527 (July 2001) “Fabrication of Three-Dimensional Microfluidic Systems by Soft Lithography,” Delamarche et al,: JOURNAL OF AMERICAN CHEMICAL SOCIETY, Vol. 120, pp. 500–508 (1998), Delamarche et al,: SCIENCE, Vol. 276, pp. 779–781 (May 1997), Quake et al., SCIENCE, Vol. 290, pp. 1536–1540 (Nov. 24, 2000), U.S. Pat. No. 6,090,251, all of which are hereby incorporated by reference). Such surface materials are preferred for their ease of manufacture, low cost and disposability, as well as their general inertness to most extreme reaction conditions. These materials may include treated surfaces, such as, derivatized or coated surfaces, to enhance their utility in the fluidic, preferably microfluidic, system, to provide enhanced fluid direction (See e.g., U.S. Pat. No. 6,238,538, and which is incorporated herein by reference).
Once cells 30 are isolated in cell isolation regions 20 of cell isolation device 10, another aspect of the invention allows for the proliferation of the cells 30 through the use of a cell expansion device. As illustrated in
Wells 122 may be of any shape, but wells with circular or square shaped top plan view (or transverse cross-sections) are preferred as these shapes are commonly used in the industry. Nothwithstanding the shape, wells 122 of expansion device 120 preferably have a greater volume than cell isolation regions 20 such as, for example, having a greater diameter (as illustrated in
Structure 121 is intended to define any number of wells 122, but preferably defines the number of wells in a standard microtiter plate such as a 24-, 96-, 384-, 768-, or 1536-well plate. More preferably, structure 121 defines the number of wells of a 385-well plate or 1536-well plate. Approximately 2 μl of liquid can be held per well 122 in a standard 1536 well plate. Larger well volumes can be achieved by extending the depth of the well 122 without compromising the correspondence between the pitch between adjacent wells 122 and the pitch between adjacent cell isolation regions 20.
In another embodiment of cell expansion device 120 as seen in
Preferably, the material used for the manufacture of cell expansion device 120 comprises any rigid or flexible material such as glass, urethanes, rubber, molded plastic, co-polymer or polymer, more preferably urethanes, rubber, molded plastic, polymethylmethacrylate (PMMA), polycarbonate, polytetrafluoroethylene (TEFLON™), polyvinylchloride (PVC), polydimethylsiloxane (PDMS), polysulfone, and the like, and most preferably PDMS. Such materials are readily manufactured from fabricated masters, using well known molding techniques, such as injection molding, embossing or stamping, or by polymerizing the polymeric precursor material within the mold. Such materials are preferred for their ease of manufacture, low cost and disposability, as well as their general inertness to most extreme reaction conditions.
Once the cells 30 are transferred from cell isolation device 10 to cell expansion device 122, the cells 30 are incubated in the cell expansion device 122, for a sufficient amount of time to allow for proliferation of cells 30. Cell expansion device 122 is intended to be used at any biologically viable temperature. Lowering the incubation temperature of the cells (i.e., from 37° C. to 18° C.) may, however, slow the metabolic processes of the cells 30 and reduce cell cloning time, thus extending the time for assay. Alternatively, media that is optimal for exhibiting the desired biological activity that is to be screened but not optimal for cell proliferation could also be used to extend the time for assay.
As illustrated in
The antibodies may be coated on prongs 142 through non-specific physisorption or through the use of SAMs on prongs 142. For example, a particular antigen may be specifically patterned on prong 142 by first evaporating gold on a polyurethane prong, then adding a self-assembling monolayer onto which an antigen can be covalently linked. (See, e.g., Mrksich et al., Annu. Rev. Biophys. Biomol. Struct., vol. 25 (1996) incorporated herein by reference). Additionally, other strategies for immobilizing protein may be employed such as lysine linkage, cutinase linkage, GST-ftision or GPI linkage.
In another embodiment of a detection device used to detect the production of antibodies from cells, such as, for example, hybridoma cells, cell isolation device 10 additionally serves as a detection device as shown in
Although in the embodiment illustrated in
Although the foregoing description of detection methods have been described in reference to production of a biological product produced by the desired biological activity being screened, the present invention contemplates the detection of any biological activity by any types of cells. Such detection methods are well known to one of skill in the art.
It will be appreciated that the present disclosure is intended to set forth the exemplifications of the invention, and the exemplifications set forth are not intended to limit the invention to the specific embodiments illustrated. The disclosure is intended to cover, by the appended claims, all such modifications as fall within the spirit and scope of the claims.
|Cited Patent||Filing date||Publication date||Applicant||Title|
|US4230685||Feb 28, 1979||Oct 28, 1980||Northwestern University||Method of magnetic separation of cells and the like, and microspheres for use therein|
|US4408625||May 7, 1982||Oct 11, 1983||Kuhl Henry Y||Article washing means with movable spray heads|
|US4508625||Oct 6, 1983||Apr 2, 1985||Graham Marshall D||Magnetic separation using chelated magnetic ions|
|US4582622||Oct 12, 1984||Apr 15, 1986||Fujirebio Kabushiki Kaisha||Magnetic particulate for immobilization of biological protein and process of producing the same|
|US4591570||Feb 2, 1983||May 27, 1986||Centocor, Inc.||Matrix of antibody-coated spots for determination of antigens|
|US4672040||Jun 28, 1985||Jun 9, 1987||Advanced Magnetics, Inc.||Magnetic particles for use in separations|
|US4729949 *||Nov 8, 1983||Mar 8, 1988||Bar-Ilan University||System and methods for cell selection|
|US4748124||Oct 30, 1984||May 31, 1988||E. I. Du Pont De Nemours And Company||Compartmentalized cell-culture device and method|
|US4777145||Oct 8, 1985||Oct 11, 1988||Labsystems Oy||Immunological assay method using magnetic particles|
|US4910148||Dec 10, 1987||Mar 20, 1990||Dynal A. S.||Magnetic separation of magnetized particles from biological fluids|
|US4988618||May 3, 1989||Jan 29, 1991||Gene-Trak Systems||Magnetic separation device and methods for use in heterogeneous assays|
|US4992377||Apr 19, 1988||Feb 12, 1991||Rolf Saxholm||Article for carrying out biological or chemical procedures containing magnetically responsive material|
|US5186827||Mar 25, 1991||Feb 16, 1993||Immunicon Corporation||Apparatus for magnetic separation featuring external magnetic means|
|US5200084||Sep 26, 1990||Apr 6, 1993||Immunicon Corporation||Apparatus and methods for magnetic separation|
|US5202227||Jun 1, 1990||Apr 13, 1993||Kanegafuchi Kagaku Kogyo Kabushiki Kaisha||Control of cell arrangement|
|US5278063||Sep 28, 1989||Jan 11, 1994||Board Of Regents The University Of Texas System||Chemical modification of promote animal cell adhesion on surfaces|
|US5330911||May 21, 1990||Jul 19, 1994||Board Of Regents, The University Of Texas System||Surfaces having desirable cell adhesive effects|
|US5395498||Nov 2, 1992||Mar 7, 1995||Gombinsky; Moshe||Method for separating biological macromolecules and means therfor|
|US5427663||Jun 8, 1993||Jun 27, 1995||British Technology Group Usa Inc.||Microlithographic array for macromolecule and cell fractionation|
|US5466574||Jan 15, 1993||Nov 14, 1995||Immunivest Corporation||Apparatus and methods for magnetic separation featuring external magnetic means|
|US5476796||Nov 14, 1994||Dec 19, 1995||Olympus Optical Co., Ltd.||Immunological test method|
|US5486457||Aug 25, 1993||Jan 23, 1996||Children's Medical Center Corporation||Method and system for measurement of mechanical properties of molecules and cells|
|US5498392||Sep 19, 1994||Mar 12, 1996||Trustees Of The University Of Pennsylvania||Mesoscale polynucleotide amplification device and method|
|US5498550||May 25, 1994||Mar 12, 1996||Nippon Telegraph & Telephone Corporation||Device for collecting or preparing specimens using magnetic micro-particles|
|US5508164||Oct 29, 1993||Apr 16, 1996||Dekalb Genetics Corporation||Isolation of biological materials using magnetic particles|
|US5514340||Jan 24, 1994||May 7, 1996||Magnetix Biotechnology, Inc.||Device for separating magnetically labelled cells|
|US5567326||Sep 19, 1994||Oct 22, 1996||Promega Corporation||Multisample magnetic separation device|
|US5573942||May 5, 1995||Nov 12, 1996||Nec Corporation||Method for arranging cells in a culture medium|
|US5591627||Oct 5, 1994||Jan 7, 1997||Nec Corporation||Apparatus for arranging cells in culture medium|
|US5593838||May 31, 1995||Jan 14, 1997||David Sarnoff Research Center, Inc.||Partitioned microelectronic device array|
|US5602028||Jun 30, 1995||Feb 11, 1997||The University Of British Columbia||System for growing multi-layered cell cultures|
|US5602042||Apr 14, 1994||Feb 11, 1997||Cytyc Corporation||Method and apparatus for magnetically separating biological particles from a mixture|
|US5603351 *||Jun 7, 1995||Feb 18, 1997||David Sarnoff Research Center, Inc.||Method and system for inhibiting cross-contamination in fluids of combinatorial chemistry device|
|US5612188||Feb 10, 1994||Mar 18, 1997||Cornell Research Foundation, Inc.||Automated, multicompartmental cell culture system|
|US5646001||Feb 28, 1995||Jul 8, 1997||Immunivest Corporation||Affinity-binding separation and release of one or more selected subset of biological entities from a mixed population thereof|
|US5660990||Aug 18, 1995||Aug 26, 1997||Immunivest Corporation||Surface immobilization of magnetically collected materials|
|US5665582||Apr 18, 1994||Sep 9, 1997||Dekalb Genetics Corp.||Isolation of biological materials|
|US5681484||May 31, 1995||Oct 28, 1997||David Sarnoff Research Center, Inc.||Etching to form cross-over, non-intersecting channel networks for use in partitioned microelectronic and fluidic device arrays for clinical diagnostics and chemical synthesis|
|US5755942||Aug 29, 1996||May 26, 1998||David Sarnoff Research Center, Inc.||Partitioned microelectronic device array|
|US5759793||Sep 30, 1994||Jun 2, 1998||Systemix, Inc.||Method for mammalian cell separation from a mixture of cell populations|
|US5763203||Mar 10, 1994||Jun 9, 1998||Sinvent As||Immobilization and separation of cells and other particles|
|US5776748||Jun 6, 1996||Jul 7, 1998||President And Fellows Of Harvard College||Method of formation of microstamped patterns on plates for adhesion of cells and other biological materials, devices and uses therefor|
|US5795470||Jun 7, 1995||Aug 18, 1998||Immunivest Corporation||Magnetic separation apparatus|
|US5812419||Jul 31, 1995||Sep 22, 1998||Abbott Laboratories||Fully automated analysis method with optical system for blood cell analyzer|
|US5858804||Aug 20, 1997||Jan 12, 1999||Sarnoff Corporation||Immunological assay conducted in a microlaboratory array|
|US5876593||Sep 15, 1997||Mar 2, 1999||Immunivest Corporation||Magnetic immobilization and manipulation of biological entities|
|US5912177||Jun 15, 1995||Jun 15, 1999||Common Services Agency||Stem cell immobilization|
|US5922284||May 19, 1998||Jul 13, 1999||Fujirebio Inc.||Method and apparatus for agglutination immunoassay|
|US5928880||Jun 11, 1997||Jul 27, 1999||Trustees Of The University Of Pennsylvania||Mesoscale sample preparation device and systems for determination and processing of analytes|
|US5968820||Feb 26, 1997||Oct 19, 1999||The Cleveland Clinic Foundation||Method for magnetically separating cells into fractionated flow streams|
|US5972721||Mar 14, 1997||Oct 26, 1999||The United States Of America As Represented By The Secretary Of The Air Force||Immunomagnetic assay system for clinical diagnosis and other purposes|
|US5989835||Feb 27, 1997||Nov 23, 1999||Cellomics, Inc.||System for cell-based screening|
|US5993665||Jun 2, 1997||Nov 30, 1999||Immunivest Corporation||Quantitative cell analysis methods employing magnetic separation|
|US5993740||Jul 17, 1997||Nov 30, 1999||Hitachi, Ltd.||Immunoassay method and analyzer using magnetic particles|
|US5998160||Nov 21, 1997||Dec 7, 1999||Csm, Inc.||Guided cell sedimentation for biological studies|
|US5998224||May 16, 1997||Dec 7, 1999||Abbott Laboratories||Magnetically assisted binding assays utilizing a magnetically responsive reagent|
|US6008010||Nov 1, 1996||Dec 28, 1999||University Of Pittsburgh||Method and apparatus for holding cells|
|US6013188||Jun 2, 1997||Jan 11, 2000||Immunivest Corporation||Methods for biological substance analysis employing internal magnetic gradients separation and an externally-applied transport force|
|US6013532||Jun 19, 1997||Jan 11, 2000||Immunivest Corporation||Methods for magnetic immobilization and manipulation of cells|
|US6027945||Jan 21, 1997||Feb 22, 2000||Promega Corporation||Methods of isolating biological target materials using silica magnetic particles|
|US6039897||Aug 28, 1997||Mar 21, 2000||University Of Washington||Multiple patterned structures on a single substrate fabricated by elastomeric micro-molding techniques|
|US6083761 *||Dec 1, 1997||Jul 4, 2000||Glaxo Wellcome Inc.||Method and apparatus for transferring and combining reagents|
|US6090251||Jun 6, 1997||Jul 18, 2000||Caliper Technologies, Inc.||Microfabricated structures for facilitating fluid introduction into microfluidic devices|
|US6110380||May 15, 1998||Aug 29, 2000||Biocrystal Ltd.||Device and method for magnetic separation of biological molecules|
|US6126835||Feb 1, 1999||Oct 3, 2000||Biocrystal Ltd.||Device and method for magnetic separation of biological molecules|
|US6133043||Apr 27, 1998||Oct 17, 2000||Igen International, Inc.||Magnetic particle based electrochemiluminescent detection apparatus and method|
|US6136182||Nov 30, 1998||Oct 24, 2000||Immunivest Corporation||Magnetic devices and sample chambers for examination and manipulation of cells|
|US6140045||Mar 6, 1997||Oct 31, 2000||Meso Scale Technologies||Multi-array, multi-specific electrochemiluminescence testing|
|US6143247||Dec 19, 1997||Nov 7, 2000||Gamera Bioscience Inc.||Affinity binding-based system for detecting particulates in a fluid|
|US6180239||Jul 8, 1996||Jan 30, 2001||President And Fellows Of Harvard College||Microcontact printing on surfaces and derivative articles|
|US6180418||Jan 20, 1998||Jan 30, 2001||The United States Of America As Represented By The Secretary Of The Navy||Force discrimination assay|
|US6184043||Jun 24, 1997||Feb 6, 2001||FODSTAD øYSTEIN||Method for detection of specific target cells in specialized or mixed cell population and solutions containing mixed cell populations|
|US6187214||Nov 13, 1998||Feb 13, 2001||Universidad De Seville||Method and device for production of components for microfabrication|
|US6221663||Jan 13, 2000||Apr 24, 2001||The General Hospital Corporation Massachusetts Institute Of Technology||Co-cultivation of cells in a micropatterned configuration|
|US6235541||May 6, 1999||May 22, 2001||The United States Of America As Represented By The Secretary Of The Navy||Patterning antibodies on a surface|
|US6238538||Apr 6, 1999||May 29, 2001||Caliper Technologies, Corp.||Controlled fluid transport in microfabricated polymeric substrates|
|US6258607||Jun 28, 1993||Jul 10, 2001||Fujirebio Inc.||Indirect agglutination immunoassay and apparatus therefor|
|US6558904||Feb 7, 1998||May 6, 2003||Clondiag Chip Technologies Gmbh||Method for producing structured, self-organized molecular monolayers of individual molecular species, in particular substance libraries|
|US20020012953||Mar 13, 2001||Jan 31, 2002||Jauho Eva Irene Stenbaek||Methods for separation and isolation of subpopulations of cells in biological samples|
|US20020022276||Sep 18, 2001||Feb 21, 2002||Yuxiang Zhou||Individually addressable micro-electromagnetic unit array chips|
|EP0390634B1||Mar 16, 1990||May 17, 1995||Societe Prolabo||Hydrophobic, cross-linked, polymeric, magnetisable composite microspheres, method for their preparation and their biological uses|
|JPS63116175A||Title not available|
|WO1992008133A1||Oct 29, 1991||May 14, 1992||Dekalb Plant Genetics||Isolation of biological materials using magnetic particles|
|WO1994011078A1||Nov 16, 1993||May 26, 1994||Immunivest Corp||Magnetic immobilization and manipulation of biological entities|
|WO1997028490A1||Jan 30, 1997||Aug 7, 1997||Dow Chemical Co||Covered microchannels and the microfabrication thereof|
|WO1999042832A1||Feb 19, 1999||Aug 26, 1999||Bio Nobile Oy||Magnetic particle transfer device and method|
|WO2000043783A2||Jan 21, 2000||Jul 27, 2000||Minerva Biotechnologies Corp||Assays involving colloids and non-colloidal structures|
|WO2000054882A1||Sep 17, 1999||Sep 21, 2000||Artloon Corp||Individually addressable micro-electromagnetic unit array chips|
|WO2000060356A1||Mar 31, 2000||Oct 12, 2000||Cellomics Inc||Miniaturized cell array methods and apparatus for cell-based screening|
|WO2001051668A1||Jan 16, 2001||Jul 19, 2001||Anthony Barnes||Ferrofluid based arrays|
|1||Beebe et al., "Microfluidic tectonics: A comprehensive construction platform for microfluidic systems", PNAS, 97(25):13488-13493 (2000).|
|2||Bhatia et al., "Selective Adhesion of Hepatocytes on Patterned Surfaces", Annals New York Academy of Sciences, 745:187-209 (1994).|
|3||Blawas et al., "Protein Patterning", Biomaterials, 19:595-609 (1998).|
|4||Boone et al., "Plastic Advances Microfluidic Devices" Analytical Chemistry, 74(3):78A-86A (2002).|
|5||Britland et al., "Micropatterning Proteins and Synthetic Peptides on Solid Supports: A Novel Application for Microelectronics Fabrication Technology", Biotechnol. Prog.., 8:155-160 (1992).|
|6||Castelino J., "Magnetic Activated Cell Sorting using Microfabricated Arrays", Biomedical Physics (1999), Session Z13.001 (abstract).|
|7||Chen et al., "Using Self-Assembled Monolayers to Pattern ECM Proteins and Cells on Substrates", Methods in Molecular Biology-Extracellular, Matrix Protocols, 139:209-218.|
|8||Chiu et al., "Patterned deposition of cells and proteins onto surfaces by using three-dimensional microfluidic systems", PNAS, 97(6):2408-2413 (2000).|
|9||Dasgupta et al., "Visualizing thin-layer, 2-D flow and chemical interaction can be done simply and cheaply", Analytical Chemistry, 74(7):209A-213A (2002).|
|10||Delamarche et al., "Microfluidic Networks for Chemical Patterning of Substrates: Design and Application to Bioassays", J. Am. Chem. Soc., 120:500-508 (1998).|
|11||Delamarche et al., "Patterned Delivery of Immunoglobulins to Surfaces Using Microfluidic Networks", Science, 276:779-781 (1997).|
|12||Fishman D. et al., "Biological Assays in Microfabricated Structures", SPIE (1999) 3603:192-197.|
|13||Folch A. et al., "Microengineering of Cellular Interactions", Annu. Rev. Biomed. Eng. (2000) 2:227-256.|
|14||Hodneland et al., "Selective immobilization of proteins to self-assembled manolayers presenting active site-directed capture ligands", PNAS, 99(8):5048-5052 (2002).|
|15||*||Hornbeck et al, "Enzyme-Linked Immunosorbent Assays (ELISA)" Current Protocols in Molecular Biology, 1991, 11.2.1-11.2.22.|
|16||Jung et al., Topographical and Physicochemical Modification of Material Surface to Enable Patterning of Living Cells, Critical Reviews in Biotechnology, 21(2):111-154 (2001).|
|17||Love J.C. et al., "Fabrication of Three-Dimensional Microfluidic Systems by Soft Lithography", MRS Bulletin (2001) 523-528.|
|18||Quake et al., "From Micro-to-Nanofabrication with Soft Materials", Science, 290(5496):1536-1540 (2000).|
|19||Safarik et al., "Use of magnetic techniques for the isolation of cells", Journal of Chromatography B, 722:33-53 (1999).|
|20||Saleemuddin, "Bioaffinity Based Immobilization of Enzymes", Advances in Biochemical Engineering/Biotechnology, 64: 203-226 (1999).|
|21||Yang et al., "I1-18-stimulated GADD45beta required in cytokine-induced, but not TCR-induced, IFN-gamma production", Abstracts 2.1-537.42 Part 1-Experimental Biology 2001, Orlando Florida, Mar. 31-Apr. 4, 2001, FASEB Journal, Abstract 537.40.|
|22||*||Yokoyama, "Production of Monoclonal Antibodies" Current Protocols in Cell Biology, 1999, 16.1.1-16.1.17.|
|Citing Patent||Filing date||Publication date||Applicant||Title|
|US8906685||Jan 28, 2011||Dec 9, 2014||The Regents Of The University Of Michigan||Hanging drop devices, systems and/or methods|
|US8951765 *||Nov 24, 2009||Feb 10, 2015||Empire Technology Development Llc||Targeted separation of cultured cells|
|US20100197004 *||Jan 30, 2009||Aug 5, 2010||United States Government, As Represented By The Secretary Of The Navy||Microtiter plate to mitigate cell distribution bias from meniscus edge|
|US20110124076 *||Nov 24, 2009||May 26, 2011||Empire Technology Development Llc||Targeted separation of cultured cells|
|US20110189723 *||Sep 2, 2009||Aug 4, 2011||National Institute Of Advanced Industrial Science And Technology||Cell detection method, and microarray chip for use in the method|
|US20120156675 *||Jun 9, 2010||Jun 21, 2012||Oxford Gene Technology Ip Limited||Picowell capture devices for analysing single cells or other particles|
|USH2268 *||Jan 30, 2009||Apr 3, 2012||The United States Of America, As Represented By The Secretary Of The Navy||Microtiter plate to mitigate cell distribution bias from meniscus edge|
|EP2407242A1||Jul 13, 2010||Jan 18, 2012||Dublin City University||Direct clone analysis and selection technology|
|WO2012007537A1||Jul 13, 2011||Jan 19, 2012||Dublin City University||Direct clone analysis and selection technology|
|U.S. Classification||435/30, 435/29, 435/326, 435/288.4, 209/17, 435/70.2, 435/4, 435/305.2, 435/325|
|International Classification||G01N35/00, G01N33/543, C12N5/06, C12M1/26, C12Q1/24, C40B60/14, C12N5/00, B01L3/00|
|Cooperative Classification||B01L2400/043, G01N33/54326, B01L3/5088, B01J2219/00659, B01J2219/00743, B01J2219/00655, B01J2219/00317, C40B60/14, B01L3/5085, C12M23/12, G01N35/0098|
|European Classification||B01L3/5085, G01N33/543D4, C12M1/26G|
|Oct 23, 2002||AS||Assignment|
Owner name: SURFACE LOGIX, INC., MASSACHUSETTS
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:WANG, EVELYN;CASAGRANDE, ROCCO;KENDALE, AMAR;AND OTHERS;REEL/FRAME:013487/0972;SIGNING DATES FROM 20021003 TO 20021008
|Dec 15, 2009||CC||Certificate of correction|
|Jul 1, 2010||FPAY||Fee payment|
Year of fee payment: 4
|Nov 29, 2010||AS||Assignment|
Owner name: SILICON VALLEY BANK, CALIFORNIA
Free format text: SECURITY AGREEMENT;ASSIGNOR:SURFACE LOGIX, INC.;REEL/FRAME:025406/0642
Effective date: 20101118
|Sep 12, 2014||REMI||Maintenance fee reminder mailed|
|Jan 30, 2015||LAPS||Lapse for failure to pay maintenance fees|
|Mar 24, 2015||FP||Expired due to failure to pay maintenance fee|
Effective date: 20150130